Artificial intelligence for volumetric measurement of cerebral white matter hyperintensities on thick-slice fluid-attenuated inversion recovery (FLAIR) magnetic resonance images from multiple centers.

Journal: Scientific reports
PMID:

Abstract

We aimed to develop a new artificial intelligence software that can automatically extract and measure the volume of white matter hyperintensities (WMHs) in head magnetic resonance imaging (MRI) using only thick-slice fluid-attenuated inversion recovery (FLAIR) sequences from multiple centers. We enrolled 1092 participants in Japan, comprising the thick-slice Private Dataset. Based on 207 randomly selected participants, neuroradiologists annotated WMHs using predefined guidelines. The annotated images of participants were divided into training (n = 138) and test (n = 69) datasets. The WMH segmentation model comprised a U-Net ensemble and was trained using the Private Dataset. Two other models were trained for validation using either both thin- and thick-slice MRI datasets or the thin-slice dataset alone. The voxel-wise Dice similarity coefficient (DSC) was used as the evaluation metric. The model trained using only thick-slice MRI showed a DSC of 0.820 for the test dataset, which is comparable to the accuracy of human readers. The model trained with the additional thin-slice dataset showed only a slightly improved DSC of 0.822. This automatic WMH segmentation model comprising a U-Net ensemble trained on a thick-slice FLAIR MRI dataset is a promising new method. Despite some limitations, this model may be applicable in clinical practice.

Authors

  • Masashi Kuwabara
    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, Hiroshima, 734-8551, Japan.
  • Fusao Ikawa
    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, Hiroshima, 734-8551, Japan. fikawa-nsu@umin.ac.jp.
  • Shinji Nakazawa
    LPIXEL Inc, 1-6-1 Otemachi, Chiyoda-Ku, Tokyo, 100-0004, Japan.
  • Saori Koshino
    Department of Radiology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
  • Daizo Ishii
    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, Hiroshima, 734-8551, Japan.
  • Hiroshi Kondo
    Department of Radiology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo, 173-8605, Japan.
  • Takeshi Hara
    Department of Psychosomatic Medicine, Endocrinology and Diabetes Mellitus, Fukuoka Tokushukai Hospital, Kasuga, Fukuoka, Japan.
  • Yuyo Maeda
    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, Hiroshima, 734-8551, Japan.
  • Ryo Sato
    Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Taiki Kaneko
    LPIXEL Inc, 1-6-1 Otemachi, Chiyoda-Ku, Tokyo, 100-0004, Japan.
  • Shiyuki Maeyama
    LPIXEL Inc, 1-6-1 Otemachi, Chiyoda-Ku, Tokyo, 100-0004, Japan.
  • Yuki Shimahara
    From the Department of Diagnostic and Interventional Radiology (D.U., A.Y., T.S., S.D., A.S., Y.M.) and Department of Premier Preventive Medicine (S.F.), Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan; LPixel, Tokyo, Japan (M.N., A.C., Y.S.); and Department of Radiology, Osaka City University Hospital, Osaka, Japan (Y.K.).
  • Nobutaka Horie
    Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, Hiroshima, 734-8551, Japan.